27546025|t|Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography / tandem mass spectrometry
27546025|a|A remediable cause of poor treatment response in drug - susceptible tuberculosis (TB) patients may be low plasma levels of one or more of the first-line anti-TB drugs. The aim of this work was to develop an accurate and precise LC-MS / MS method for simultaneous quantification of all four first-line anti-TB drugs in plasma suitable for therapeutic drug monitoring (TDM). To adjust for degradation and losses during sample preparation, isotopically labeled compounds were used as internal standards. Plasma samples spiked with internal standards were extracted using protein precipitation with methanol and acetonitrile. Simultaneous separation of all four drugs was accomplished with a Chromolith Reversed-Phase column and mobile phases consisting of water, methanol, ammonium acetate and formic acid with subsequent mass spectrometric quantification. The linear range of the calibration curve for isoniazid was 0.5-10 mg/L, for rifampicin 0.75-30 mg/L, for ethambutol 0.25-10 mg/L and for pyrazinamide 4-80 mg/L. The lower limit of quantification was 0.5 mg/L, 0.75 mg/L, 0.25 mg/L and 4.0 mg/L, respectively. Precision estimated by the coefficient of variation was <15% for all four drugs. The LC-MS / MS method can readily be used for simultaneous quantification of first-line anti-TB drugs in plasma and is well suited for TDM.
27546025	0	12	Simultaneous	T079	C0521115
27546025	13	27	quantification	T081	C1709793
27546025	31	40	isoniazid	T109,T121	C0022209
27546025	42	52	rifampicin	T109,T195	C0035608
27546025	54	64	ethambutol	T109,T121	C0014964
27546025	69	81	pyrazinamide	T109,T121	C0034239
27546025	85	106	liquid chromatography	T059	C0008565
27546025	109	133	tandem mass spectrometry	T059	C2123592
27546025	136	146	remediable	T058	C1709895
27546025	156	179	poor treatment response	T033	C1320680
27546025	183	187	drug	T121	C1254351
27546025	190	201	susceptible	T169	C0231204
27546025	202	214	tuberculosis	T047	C0041296
27546025	216	218	TB	T047	C0041296
27546025	220	228	patients	T101	C0030705
27546025	236	239	low	T080	C0205251
27546025	240	246	plasma	T031	C0032105
27546025	247	253	levels	T080	C0441889
27546025	287	300	anti-TB drugs	T195	C0003237
27546025	306	309	aim	T078	C1947946
27546025	341	349	accurate	T080	C0443131
27546025	362	367	LC-MS	T059	C0872318
27546025	370	372	MS	T059	C0037813
27546025	384	396	simultaneous	T079	C0521115
27546025	397	411	quantification	T081	C1709793
27546025	435	448	anti-TB drugs	T195	C0003237
27546025	452	458	plasma	T031	C0032105
27546025	472	499	therapeutic drug monitoring	T061	C1720825
27546025	501	504	TDM	T061	C1720825
27546025	521	532	degradation	T169	C0243125
27546025	537	543	losses	T081	C1517945
27546025	551	569	sample preparation	T059	C3824791
27546025	571	601	isotopically labeled compounds	T196	C0022262
27546025	635	649	Plasma samples	T031	C0444263
27546025	686	695	extracted	T059	C0022885
27546025	702	723	protein precipitation	T059	C3815102
27546025	729	737	methanol	T109,T131	C0001963
27546025	742	754	acetonitrile	T109	C0050456
27546025	756	768	Simultaneous	T079	C0521115
27546025	769	779	separation	UnknownType	C0678621
27546025	792	797	drugs	T121	C0013227
27546025	822	854	Chromolith Reversed-Phase column	T075	C1705246
27546025	859	872	mobile phases	T130	C3469601
27546025	887	892	water	T121,T197	C0043047
27546025	894	902	methanol	T109,T131	C0001963
27546025	904	920	ammonium acetate	T109,T130	C0051704
27546025	925	936	formic acid	T109,T121,T130	C0016576
27546025	953	971	mass spectrometric	T059	C2123592
27546025	972	986	quantification	T081	C1709793
27546025	992	1004	linear range	T081	C1514721
27546025	1012	1029	calibration curve	T081	C0392762
27546025	1034	1043	isoniazid	T109,T121	C0022209
27546025	1065	1075	rifampicin	T109,T195	C0035608
27546025	1094	1104	ethambutol	T109,T121	C0014964
27546025	1126	1138	pyrazinamide	T109,T121	C0034239
27546025	1154	1183	lower limit of quantification	T081	C2826316
27546025	1247	1256	Precision	T079	C1547902
27546025	1257	1266	estimated	T081	C0750572
27546025	1274	1298	coefficient of variation	T081	C0681921
27546025	1321	1326	drugs	T121	C0013227
27546025	1332	1337	LC-MS	T059	C0872318
27546025	1340	1342	MS	T059	C0037813
27546025	1374	1386	simultaneous	T079	C0521115
27546025	1387	1401	quantification	T081	C1709793
27546025	1416	1429	anti-TB drugs	T195	C0003237
27546025	1433	1439	plasma	T031	C0032105
27546025	1463	1466	TDM	T061	C1720825